Spectrum Pharmaceuticals’ CRL: There Is Very Little Clarity
Zhanna Kavaliova/iStock via Getty Images
It is embarrassing to read the titles of my last three articles on Spectrum Pharmaceuticals (NASDAQ:SPPI).
Source
It is embarrassing because a few days after my last article came out, we had this:
Source
My thesis…
